HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ONXX: Onyx Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
ONYX PHARMACEUTICALS INC (NASD)
ONXX 28.08 0.09 (0.32%) Vol.  432,469 16.00 CST

Nov 19, 2009 Onyx Pharmaceuticals Down 5.2% Since SmarTrend's Sell Recommendation
Nov 18, 2009 Onyx Pharmaceuticals completes acquisition of Proteolix
Nov 16, 2009 xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : ADPI, FISV, ONXX and NEOG
Nov 16, 2009 Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc.
Nov 13, 2009 Stock research report available on Onyx Pharmaceuticals (NASDAQ:ONXX) from SmarTrend Analytics
Nov 12, 2009 Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com
Nov 12, 2009 TheFortuneFinancial.com Research Partners Tracking WFMI, ONXX, ARBA,MSCC, GNTX and EWBC
Nov 11, 2009 Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 10, 2009 Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib and ONX 0803 at 51st American Society of Hematology Annual Meeting
Nov 04, 2009 Onyx Pharmaceuticals Down 10.6% Since SmarTrend's Sell Recommendation
Nov 04, 2009 Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
Nov 04, 2009 Affymax Inc elects Hollings C. Renton as chairman
Nov 03, 2009 Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Oct 29, 2009 MONSTERSTOX.COM: Monsterstox.com : Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX)
Oct 29, 2009 Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
 
ZACKS COMMENTARY FOR ONXX
Nov 04, 2009 Zacks Blog: Onyx Beats Estimates
Oct 21, 2009 Zacks Blog: FDA Approval for GlaxoSmithKline
Oct 12, 2009 Zacks Blog: Onyx to Acquire Cancer Drugmaker
Oct 06, 2009 Zacks Blog: FDA Panel Backs Glaxo’s Votrient
Sep 25, 2009 Zacks Blog: Bayer on a High
Sep 23, 2009 Zacks Blog: Bayer’s Cancer Drug Shows Benefit
Jul 27, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Onyx, Starwood Hotels and Resorts Worldwide, D.R. Horton, Lennar and Beazer
Jul 27, 2009 Bull of the Day: Onyx Pharma - ONXX
Jul 24, 2009 Zacks Equity Research: Report for ONXX
Jun 01, 2009 Zacks Blog: Zacks Industry Outlook Highlights: Myriad Genetics, Onyx Pharmaceuticals Inc., AMAG Pharmaceuticals Inc., Dendreon and 3SBio Inc.
May 07, 2009 Zacks Blog: Onyx Misses, but Outlook Positive
Apr 28, 2009 Zacks Blog: Ardea Lands Bayer Partnership

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research